AveXis Company

AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.

Industry: Gene Therapy
Technology: Rare Genetic Disorders
Funding Status: M&A
Estimated Revenue: $1B to $10B
Headquarters: Dallas, Texas, United States
Founded Date: 2013